Table 2.
Tandem Lesion (N=60) | Isolated Intracranial (319) | P | |
---|---|---|---|
LKW-to-Alteplase Min, Median (IQR) | 120 (92–163) | 112 (83–156) | 0.323 |
Intravenous Alteplase | 39 (65%) | 174 (55%) | 0.157 |
LKW-Groin Min, Median (IQR) | 328 (197–425) | 267 (180–368) | 0.018 |
Acute Treatment Approach | |||
Cervical ICA Before Intracranial LVO | 34 (57%) | - | |
Cervical ICA After Intracranial LVO | 8 (13%) | - | |
No Cervical ICA Acute Treatment | 13 (22%) | - | |
Cervical ICA Inaccessible | 5 (8%) | - | |
Acute Treatment Type (N=42) | |||
Cervical ICA stent | 34 (81%) | - | |
Cervical ICA angioplasty alone | 8 (19%) | - | |
Number EVT Passes, Median (IQR) | 2 (1–2) | 1 (1–1.5) | 0.087 |
TICI 2b-3 | 35 (58%) | 263 (82%) | <0.0001 |
ICH | 8 (13%) | 16 (5%) | 0.037 |
Follow-Up Stent Patency (N=22) | 12 (55%) | - | - |
90-Day mRS 0–2 | 18 (34%) | 121 (43%) | 0.288 |
90-Day Mortality | 12 (23%) | 62 (22%) | 0.859 |